Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannTrust Holdings Inc CNTTQ

CannTrust Holdings Inc is engaged in the business of producing and distributing medical cannabis in Canada. Its facility is located at Vaughan, Ontario in Canada. Its brands include LIIV, ESCAPE, SYNR.G and Peak Leaf.


GREY:CNTTQ - Post by User

Bullboard Posts
Post by BIBI123on Aug 18, 2018 7:12am
382 Views
Post# 28481684

Some mind blowing calculations

Some mind blowing calculations
Please take the time and read this post, these are all FACTS. Investing in Canntrust at these prices is a no-brainer. We have 17 tonnes signed with provinces, at a price of probably 5$/g that is $85m. For the medical sales, at a rate of 15% increase QoQ we will be making on average almost $15m in revenues per quarter,which is $60m per year. That is together $145m in revenue that we KNOW we're gonna make. We don't know how much are beverages/edibles gonna bring, but probably a lot. In addition, Ontario hasn't announced any MOUs yet. I noticed that GMP raised Canopy's price target to $50 and they expect them to have $470m in revenues for the 2019 and I calculated a PS ratio and they gave them a 37x sales. Now, if we put just 15x sales on Canntrust's revenue of $150m, we would get a market cap of $2.25b, which would reflect in a share price of almost $22. Bottom line is that this company is really undervalued! These are all numbers, which we know we're gonna see for sure, but the probability of seeing better revenues than expected is extremely high. Cheers
Bibi
Bullboard Posts